The direct-to-consumer healthcare market encompasses an array of medicine, digital therapeutics, primary and specialty providers, and innovative technologies. Examples include concierge medical services, medical spas, weight loss centers, mindfulness programs, sexual and sleep health services, luxury rehab facilities, clinically validated skincare and longevity services, and “food as medicine” programs. Projections indicate that the global health and wellness market is anticipated to reach a substantial USD 9.2 trillion by 2033 (Precedence Research, 2024). To provide the best possible experience and outcomes for consumers and maximize returns for investors, these services require a leadership team that is a unique hybrid of backgrounds and experiences.
Historically, investment focus in healthcare followed a traditional healthcare business model, with specialty physician practices, urgent care centers, and other traditional healthcare environments responding to illnesses, accidents, and emergencies as they occur with their patients. The industry is undergoing significant transformation, however, as consumers take a more active and direct interest in their own health and wellness. According to McKinsey research, 82% of US consumers now consider wellness a top or important priority in their everyday lives (McKinsey, 2023). This increased consumer demand is a significant factor at play in the recent increased interest from the investor market: PitchBook’s 2023 Q4 Health Services report identified medical spas as the number one exception to the general healthcare trend of declining deal activity and valuations in 2023, with a positive outlook for sustained investor interest. This shift is also driven by a desire from investors and providers to tap into markets not dependent on payers and traditional reimbursement models.
The direct-to-consumer healthcare sector offers a number of other qualities appealing to investors:
The combination of promising benefits, lower barriers and cost of entry, and high growth potential has sparked an increased interest from private equity investors who see the opportunity in direct-to-consumer healthcare to deliver positive results to consumers and enhance fund performance alongside.
Additionally, this presents an advantage for investors to disrupt a market and potentially roll up the fragmented industry, capturing market share in the process. PitchBook’s data shows a proliferation in medical spas over the past decade (PitchBook, 2023), acknowledging that until the latter half of 2023, the industry was too fragmented to be wholly appealing to middle-market investment firms. According to PitchBook’s data, 2023 saw the most growth deals in aesthetic dermatology to date, with at least eight growth deals announced in the first 10 months of 2023 — compared to just one in 2020 (Burleson, 2023). This heightened interest in direct-to-consumer healthcare extends to concierge medicine and subscription-based healthcare delivery. As a result, an estimated 5,000 to 7,000 concierge medicine programs and subscription-based healthcare delivery physicians now operate within the United States, sparking interest from private equity investors (DataHorizzon Research, 2024; Fierce Healthcare, 2024).Private equity firms entering the direct-to-consumer healthcare sector can leverage several key value-creation strategies.
These include implementing subscription or membership options, enhancing the patient experience, exploring consumer financing options, scaling up service portfolios, and diversifying revenue streams. Furthermore, technology offers additional avenues for value creation: investing in advanced technological solutions for a broader spectrum of procedures, leveraging artificial intelligence (AI) to optimize digital marketing efforts, and providing consumers with access to longitudinal health, among other innovative strategies.
The sector demonstrates significant growth potential, buoyed by cultural shifts that foster increased consumer acceptance, empowerment, and engagement. Beyond these overarching trends, specific attributes of the direct-to-consumer offerings fuel robust and sustained market expansion, including strong customer loyalty, inherent growth, less stringent regulatory oversight, a focus on subscription models, and the consumer preference for an increasingly personalized healthcare experience where they feel their healthcare providers truly listen to them. McKinsey’s 2024 Future of Wellness study underscores the ripe opportunities for innovation and investment in women’s health, weight management, and in-person fitness (McKinsey, 2023).
In alignment with market growth projections and the evolving consumer embrace of health and wellness as a core consumption category, the industry is on the brink of significant transformations, most notably:
This approach allows consumers to make informed decisions and explore various healthcare options while seeking validation from their trusted healthcare providers.
In a quickly evolving landscape with no signs of slowing down, it is imperative for investors tometiculously select their leadership teams, recognizing the unique blend of skillsets necessary for success in direct-to-consumer healthcare.
Moreover, leaders and teams must be adept at navigating significant growth and expansion while simultaneously embracing the importance of brand differentiators and the lifetime value of their customers. In the direct-to-consumer healthcare sector, transformative leadership is crucial for driving innovation, growth, and customer-centricity.
Competencies and skillsets brought by executives coming from rather traditional healthcare backgrounds:
Competencies and skillsets brought by executives coming from consumer health and wellness backgrounds:
For leaders, regardless of their prior institutional experience, financial acumen and value creation are essential competencies. They must demonstrate a proven track record of driving revenue growth through innovative business models and go-to-market excellence, as well as effectively communicating the company’s vision and strategy to stakeholders.
In organizations operating in or pivoting to direct-to-consumer healthcare, the ability of leadership teams to embrace consumer centricity is a core principle. Here are a few leadership initiatives essential for navigating the shift towards consumer-centric healthcare to drive innovation and value creation.

WittKieffer’s capabilities in executive search, leadership advisory, and interim/on-demand leadership solutions help investors and organizations develop transformative and impactful leadership.
In conclusion, the shift towards direct-to-consumer healthcare represents a significant opportunity for investors and healthcare providers to deliver positive results to consumers while enhancing investment performance. The success of this sector is driven by a unique blend of skillsets and experiences, requiring a leadership team that can navigate significant growth and expansion while maintaining a steadfast consumer focus and improving patient outcomes. As the industry continues to evolve and transform, it is imperative for investors and healthcare providers to meticulously select and develop their leadership teams, embracing the importance of consumer centricity, brand differentiation, and the lifetime value of customers. With the right leadership in place, the direct-to-consumer healthcare sector is poised for significant growth and success in the years to come.

Shelly Carolan, Managing Partner, Investor-backed Healthcare, has broad and deep expertise across the healthcare and life sciences industries and in particular in for-profit healthcare. Prior to her career in executive recruitment, she held a number of C-suite positions at PE-backed and private healthcare service organizations. As leader of WittKieffer's Investor-Backed Healthcare Practice, she conducts and oversees high-level searches and manages quality, and consistency of the teams work for for-profit healthcare clients.